Abstract. Retinitis pigmentosa (RP) is a pathological condition leading to progressive visual decline resulting from continual loss of photoreceptor cells and outer nuclear layers of the retina. The aim of the present study was to explore whether melanopsin was able to restore retinal function and inhibit its degeneration by acting in a similar manner to channel rhodopsins. Royal College of Surgeons rats, which were used as an animal model of inherited retinal degeneration, were subjected to sub-retinal injection with melanopsin overexpression vector (AV-OPN4-GFP). Immunohistochemical and western blot analyses were used to detect the distribution and protein expression of melanopsin in the retina, revealing that melanopsin was gradually reduced with increasing age of the rats, which was due to loss of dendritic axons of intrinsically photosensitive retinal ganglion cells. Animals injected into both eyes were subjected to a behavioral open-field test, revealing that melanopsin overexpression reduced the loss of light sensitivity of the rats. In a flash electroretinography experiment, the b-wave and response to light flash stimuli at three and five weeks following injection with AV-OPN4-GFP were higher compared to those in eyes injected with AV-GFP (P<0.05). In conclusion, the present study showed that during retinal degeneration, the expression of melanopsin was significantly decreased, while vector-mediated overexpression of melanopsin delayed the loss of visual function in rats.
Introduction
Retinitis pigmentosa (RP) is an pathological condition leading to progressive visual decline resulting from continual loss of photoreceptor cells and outer nuclear layers of the retina (1) . At present, no cures for this degenerative retinal disease are available. Experimental approaches for the development of treatments of RP have advanced in recent years, which include drug treatments (2,3), stem-cell transplantation (4), gene therapy (5) and light sensitivity-modulating proteins (6) .
Treatment approaches using light sensitivity-enhancing proteins such as channel rhodopsins (ChR) and melanopsin have recently emerged as a hotspot of RP research. ChR2, which was first described in green algae, is a light-gated ion channel which evokes ultrafast membrane depolarization and mediates an action potential (7, 8) . Of note, ChR2 has been demonstrated to be able to restore the function of degenerative retinal diseases. Unlike ChR2, the photopigment melanopsin is expressed by intrinsically photosensitive retinal ganglion cells (ipRGC) in the human retina (9) . Melanopsins mediate a broad range of physiological responses, including circadian rhythm, modulation of sleep and alertness (10) (11) (12) . The light-evoked response mediated by melanopsin is slower but more durable than that of ChR2 in the absence of photoreceptor-based input (12) . However, whether melanopsin has the potential to restore visual function similarly to ChR2 has remained elusive. Therefore, the present study evaluated the effects of melanopsin in Royal College of Surgeons (RCS) rats, which are widely used as a model of inherited retinal degeneration. These animals carry a mutation in the Mertk gene expressed in retinal pigment epithelial cells, which results in progressive photoreceptor cell death and loss of electrophysiological response (13, 14) . The present study aimed to determine whether sub-retinal injection of melanopsin-overexpressing adenovirus may restore visual function in RCS rats in order to explore the feasibility of using melanopsin as a novel therapeutic for retinal degenerative diseases.
Materials and methods
Experimental animals. A total of 18 healthy neonatal RCS rats (4-week-old) were provided by the Experimental Animal Center of Southwest Hospital, Third Military Medical University (Chongqing, China) of mixed gender. Of these rats, 10 were used for behavioral testing and 8 were used for flash electroretinography (FERG). Prior to the start of the experiments, the rats were acclimatized for 1 week. The rats were reared in a light-controlled room with a 12-h light/dark cycle at 22-25˚C and 50-60% humidity. All experimental protocols were in accordance with the Guidance Suggestions for the Care and Use of Laboratory Animals, formulated by the Ministry of Science and Technology of the People's Republic of China (15) , and approved by the ethics committee of the Third Military Medical University (Chongqing, China). Experiments were performed in the laboratory of Southwest Eye Hospital from August 2012 to December 2013.
V i ra l ve c t o rs.
Two v i r a l ve c t o r s we r e u s e d: Adenovirus -opsin4 -green fluorescent protein (AV-Opn4-GFP) and the empty vector AV-GFP. Full-length mouse melanopsin (GenBank accession no. 6693702) was cloned into pAV vector under the transcriptional control of the murine cytomegalovirus promoter. These two constructs were packaged at the GeneChem Biological Company virus production core (Shanghai, China). The packaged viruses were concentrated and dissolved in phosphate-buffered saline (PBS) to 1.08 or 2.2x10 13 genome copies per milliliter for AV-Opn4-GFP or AV-GFP, respectively.
Sub-retinal injection of adenovirus. For anesthesia, animals at the age of five weeks were subjected to intramuscular thigh injection with a mixture of 10 mg/kg ketamine (Sigma-Aldrich, St. Louis, MO, USA) and 1 mg/kg xylazine (Sigma-Aldrich). Oxybuprocaine 0.4% (Santen Pharmaceutical Co., Ltd., Osaka, Japan) eye drops were used for superficial anesthesia. Under aseptic conditions, the RCS rats were individually moved to an animal operating table under a microscope on a biological super-clean bench. 2 µl viral suspension was injected into the sub-retinal space in the superior hemisphere of the eyes. In the group subjected to behavioral testing, five rats received AV-Opn4-GFP injection into both eyes in the experimental group, while the control group consisted of five untreated RCS rats. In the group subjected to FERG testing, in order to avoid individual differences, the right eye of the rats received AV-Opn4-GFP injection, while the left eye was injected with a control viral vector (AV-GFP; n=8).
Immunohistochemistry. At 3, 5 and 7 weeks following injection with the vectors, the eyes were immediately enucleated from RCS rats sacrificed by decapitation under deep anesthesia via intramuscular injection of 20 mg/kg ketamine and 2 mg/kg xylazine. For immunohistochemical analysis, the whole-mount retina was isolated and blocked with 5% bovine serum albumin (Beyotime Institute of Biotechnology, Haimen, China) diluted in 10% goat serum (Beyotime Institute of Biotechnology) in PBS for 1 h at room temperature (25˚C). The blocked retina was washed with PBS for 5 min for times. Next, the retina was incubated with rabbit anti-mouse anti-melanopsin polyclonal antibody (1:500; cat. no. ab19306; Abcam, Cambridge) overnight at 4˚C and washed in PBS three times for 15 min each. Subsequently, the retinas were incubated with Cy3-conjugated goat anti-rabbit immunoglobulin G (1:500; cat. no. A0516; Beyotime Institute of Biotechnology) for 4 h at room temperature and washed three times in PBS for 15 min each. A fluorescence microscope (Zeiss LSM 510, Carl Zeiss AG, Oberkochen, Germany) was used to capture images. The number of ipRGCs was counted by fluorescence microscopy under x200 magnification. For each sample, nine fields of view with the same size (200x300 µm) were randomly selected. The length of the axons was also measured under a fluorescence microscope (x400 magnification) and 27 cells were randomly selected (16, 17) .
Western blot analysis. The retina was isolated using the liquid nitrogen method (17) and lysed using a cell lysis solution [50 mM Tris-HCl buffer (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, sodium orthovanadate, sodium fluoride, EDTA and leupeptin; P0013B; Beyotime Institute of Biotechnology]. The cell lysates were separated by 12% SDS-PAGE and electrotransferred onto nitrocellulose (NC) membranes (Whatman, Fairfield, CT, USA). After blocking with 5% de-fatted milk in PBS containing 0.05% Tween-20 overnight at 4˚C, the membranes were incubated with the anti-melanopsin antibody overnight at 4˚C. After washing, all membranes were incubated with rat polyclonal GAPDH antibody (1:1,000; cat. no. CW0101; CWBio, Beijing, China) for 1 h at room temperature and horseradish peroxidase-conjugated goat anti-rabbit IgG (1:2,000; cat. no. A0208; Beyotime Institute of Biotechnology) at room temperature for 1 h. The NC membranes were visualized using an enhanced chemiluminescence kit (Applied Biosystems; Thermo Fisher Scientific, Waltham, MA, USA) and scanned using the Odyssey infrared imaging system with the Odyssey Application software (V1.2.15; LI-COR Biosciences, Lincoln, NE, USA). Quantification of melanopsin was performed by densitometric analysis of the protein bands (16, 17) .
Open field test.
The open field test box was 45x30x40 cm in size and divided into a white open field and a dark zone with a door (10x10 cm) between them. To test rats in the open field (5 weeks post-injection), the rats were placed in the dark zone for 2 min for adaptation and the door was then opened to observe the behavior of the rats. The time spent in the dark zone and white open field was recorded. The open field test was performed under 300 lux light intensity and recorded using a video camera to enable subsequent evaluation. The bottom surface of the box was cleaned with 70% ethanol prior to testing of each animal (18, 19) .
FERG recording. FERG recording was performed on animals at 3, 5 and 7 weeks following injection with melanopsin-overexpression/empty vector. Animals were allowed to adapt to darkness for almost 12 h and prepared for recording under dim red light. After anesthesia, pupils were dilated with tropicamide and phenylephrine eye drops (Santen Pharmaceutical Co., Ltd). FERG responses of both eyes were recorded simultaneously using goldwire loops (Roland Consult, Brandenburg a.d. Havel Germany). The cornea was frequently treated with 0.9% saline to prevent its de-hydration and allow electrical contact with the recording electrode. Two needle electrodes were inserted under the skin of the angulus oculi temporal to serve as reference electrodes, while the other electrodes were placed in the tail to serve as the grounding electrodes. The b-waves were acquired using the Reti-scan system (Roland Consult, Brandenburg a.d. Havel, Germany). Dark-adapted intensity responses to stimuli with intensities of -0.5, -0.02, 0.5 and 1 Log(cd sec/m 2 ) were measured. To avoid any adapting effect of the previous flash, the flash interval was set as 60-120 sec depending on stimulus intensity.
Statistical analysis. Data analysis was performed using the SPSS 13.0 statistical package (SPSS, Inc., Chicago, IL, USA). Values are expressed as the mean ± standard deviation. Data were analyzed using the independent-samples t test to compare the differences between two treatment modalities/groups in the FERG and behavioral experiments. P<0.05 was considered to indicate a statistically significant difference between values.
Results

Melanopsin expression is decreased during retinal degradation due to loss of dendritic axons.
Western blot analysis demonstrated that in the retinal degeneration model, melanopsin expression levels in the retinas of rats aged 30, 60 and 90 days decreased with increasing age (Fig. 1A) . However, during this time, the number of melanopsin-positive cells did not decrease, as indicated by immunohistochemistry (Fig. 1B and C) . Assessment of the average axon length of ipRGCs revealed significant shortening after 60 and 90 days compared with axon length at 30 postnatal days (Fig. 1D) . These results confirmed that in RCS rats as a model of chronic retinal degeneration, melanopsin expression is gradually decreased with increasing age. This diminished expression of melanopsin was demonstrated to result from the decreased length of dendritic axons of ipRGCs, but not the loss of the number of ipRGCs.
Vector-mediated overexpression of melanopsin. The retinas of rats at 3, 5 and 7 weeks following injection of AV-OPN4-GFP (at the age of 8, 10 and 12 weeks, respectively) were subjected to western blot analysis of melanopsin. The results confirmed that at 3 and 5 weeks following sub-retinal injection of AV-OPN4-GFP, a significant overexpression of melanopsin was achieved in the retina, compared with its expression in the control vector-injected eyes (P<0.05) (Fig. 2) .
Melanopsin overexpression in retina reduces loss of light sensitivity in RCS rats.
Previous studies have demonstrated that normal rats avoid open, bright spaces, and that this innate tendency can be utilized as the basis of a simple test of their ability to detect light (18, 19) . In the open-field test, rats are placed in an illuminated open field with access to a dark zone. The time spent by the rats in the open space is recorded using a camera. The total time of the test is 300 sec. The results showed that the RCS rats at 10 weeks of age injected with the empty vector AV-GFP did not possess a sufficient number of photoreceptors to mediate light avoidance, resulting in 217.8±24.13 sec (n=5) in the dark zone, whereas RCS rats injected with AV-OPN4-GFP spent 292.4±5.59 sec (n=5) in the dark zone (P<0.05) (Fig. 3) . This result indicated that melanopsin overexpression in the retina inhibited the loss of light sensitivity in a rat model of ongoing retinal degradation. A B abolished at 60 days of age (20) . In the present study, the b-wave amplitude at 10 weeks of age was reduced compared with that at 8 weeks of age, and was completely abolished at 12 weeks of age in the rat eyes injected with empty vector (Fig. 4A) . However, the eyes of RCS rats which had received sub-retinal injections of AV-OPN4-GFP at the age of five weeks showed an enhanced b-wave amplitude compared with that of empty vector-injected eyes at 8 and 10 weeks of age (n=8) (Fig. 4A) . However, at 12 weeks, the amplitude of the b-waves in the melanopsin-overexpressing eyes could not be restored. Similarly, the response to stimuli with dosed light flashes at various intensities was decreased in the empty vector-injected eyes at weeks 10 and 12 of age compared with that at 8 weeks. In the eyes injected with AV-OPN4-GFP, the response was significantly increased compared with that of empty vector-injected eyes at 8 and 10 weeks of age (P<0.05); however, differences were not significant at 12 weeks of age (P>0.05) (Fig. 4B ).
Discussion
The structure of the mammalian retina is highly organized and all light detection is performed by two visual pathways:
The image-forming and the non-image-forming systems (21) . In the traditional model, the retina contains two types of photoreceptor -the rod and the cone. These perform the first step of the visual process by capturing light and transducing it into electrical signals. However, in recent years, a novel type of specialized retinal ganglion cell, namely the ipRGC, was discovered, which expresses the photopigment melanopsin and is intrinsically photosensitive (21, 22) . Upon their discovery, ipRGCs were first considered to be involved in the circadian rhythm, and within the last few years it has become evident that these photoreceptors mediate light detection to regulate behavioral and physiological responses to light (23, 24) . It has now been suggested that the ipRGC family has up to five distinct cell types (termed M1-5) with various morphological characteristics and locations of their dendritic arbors (25) . M1 ipRGCs are well established as predominantly being responsible for circadian photoentrainment and the pupillary light reflex (26, 27) . The non-M1 ipRGCs may be responsible for image-forming behaviors via projection to the lateral geniculate nucleus (28) . In addition, a study on bipolar cells showed that bipolar axons communicate with outer stratifying melanopsin cells in the retina of primates (29) . FERG is a widely used method for detecting the entire function of the retina. With the aggravation of retinal degeneration, RCS rats are depleted of almost all of their rods and cones, and in spite of a few surviving cells, retinal function is almost completely lost, followed by the complete abolishment of the electrophysiological response (20) . In the present study, western blot and immunofluorescence analysis were used to assess melanopsin expression during retinal degeneration, revealing that its protein expression was gradually decreased, particularly at 60 postnatal days. The length of retinal axons was significantly shortened after 30 postnatal days. A viral vector was used to deliver melanopsin to the retina in order to supplement the reduced melanopsin levels with the aggravation of retinal degeneration; this led to a delay in the time-dependent loss of the b-wave response. Of note, these findings indicated a role for melanopsin and ipRGCs in the image-forming systems of the eye.
Behavioral studies have shown that normal rat avoids open, bright spaces, while the rats with retinal degeneration spend a decreased amount of time in a dark area (18, 19, 30) . Of note, in the present study RCS rats sub-retinally injected with AV-OPN4-GFP spent a longer duration in the dark zone compared with untreated RCS rats. This indicated that melanopsin may be able to delay retinal degradation or enhance the efficiency of the remaining photoreceptors in the retina, leading to an increased electrical signal and light sensitivity. In addition, the FERG assay showed that melanopsin rescued the electrophysiological response to the flashed light, which was transmitted to the image-forming system. Therefore, modulation of melanopsin expression may be a novel therapeutic method for treating patients with retinal degeneration. However, the life time of the AV used to deliver melanopsin into the sub-retinal region was relatively low, as in the present study, its effects were diminished at 7 weeks following injection in terms of protein expression of melanopsin and the b-wave response. Thus, a further study by our group will use adeno-associated virus instead of AV for the delivery of melanopsin, which may be more suitable for use in vivo. Future studies should be performed to enhance the current understanding of the molecular mechanisms of action of the endogenous opsin melanopsin, including regulation of the electrophysiological response to flash light and the effects of its modulation on visual performance.
